Suppr超能文献

1型人类免疫缺陷病毒载体能有效地转导人类造血干细胞。

Human immunodeficiency virus type 1 vectors efficiently transduce human hematopoietic stem cells.

作者信息

Sutton R E, Wu H T, Rigg R, Böhnlein E, Brown P O

机构信息

Department of Biochemistry and Howard Hughes Medical Institute, Stanford University Medical Center, Stanford, California 94305, USA.

出版信息

J Virol. 1998 Jul;72(7):5781-8. doi: 10.1128/JVI.72.7.5781-5788.1998.

Abstract

Lentiviruses are potentially advantageous compared to oncoretroviruses as gene transfer agents because they can infect nondividing cells. We demonstrate here that human immunodeficiency virus type 1 (HIV-1)-based vectors were highly efficient in transducing purified human hematopoietic stem cells. Transduction rates, measured by marker gene expression or by PCR of the integrated provirus, exceeded 50%, and transduction appeared to be independent of mitosis. Derivatives of HIV-1 were constructed to optimize the vector, and a deletion of most of Vif and Vpr was required to ensure the long-term persistence of transduced cells with relatively stable expression of the marker gene product. These results extend the utility of this lentivirus vector system.

摘要

与致癌逆转录病毒相比,慢病毒作为基因传递载体具有潜在优势,因为它们可以感染非分裂细胞。我们在此证明,基于人类免疫缺陷病毒1型(HIV-1)的载体在转导纯化的人类造血干细胞方面效率很高。通过标记基因表达或整合前病毒的PCR测量的转导率超过50%,并且转导似乎与有丝分裂无关。构建了HIV-1的衍生物以优化载体,并且需要删除大部分Vif和Vpr以确保转导细胞的长期存活以及标记基因产物的相对稳定表达。这些结果扩展了这种慢病毒载体系统的用途。

相似文献

10
Regulation of HIV-1 gene expression.HIV-1基因表达的调控
FASEB J. 1991 Jul;5(10):2361-8. doi: 10.1096/fasebj.5.10.1712325.

引用本文的文献

本文引用的文献

6
Development of HIV vectors for anti-HIV gene therapy.用于抗HIV基因治疗的HIV载体的开发。
Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11395-9. doi: 10.1073/pnas.93.21.11395.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验